ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,960,298 | -25.2% | 259,036 | 0.0% | 2.07% | +5.5% |
| Q2 2023 | $9,307,163 | +41.5% | 259,036 | 0.0% | 1.96% | -11.2% |
| Q1 2023 | $6,579,514 | -25.8% | 259,036 | +17.2% | 2.21% | -34.3% |
| Q4 2022 | $8,867,122 | +51.9% | 221,015 | +26.0% | 3.36% | +58.5% |
| Q3 2022 | $5,837,000 | -5.5% | 175,393 | 0.0% | 2.12% | +3.7% |
| Q2 2022 | $6,176,000 | -26.5% | 175,393 | -4.0% | 2.05% | +10.1% |
| Q1 2022 | $8,403,000 | -39.0% | 182,717 | -10.6% | 1.86% | -31.9% |
| Q4 2021 | $13,766,000 | – | 204,393 | – | 2.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |